X-ray-Excited Persistent Luminescence of Tb3+-Doped Fluoride Nanoparticles for Photodynamic Therapy
Source abstract
Abstract
X-ray-excited persistent luminescence (XEPersL) of fluoride nanoparticles (NPs) is of great potential in X-ray excitation photodynamic treatment (X-PDT) and X-ray detection fields. However, their practical application is currently impeded by the hazard of X-rays with high dose rates to the human body and low luminescence efficiencies. Here, we reported a feasible strategy for modulating X-ray excited optical luminescence (XEOL) intensities and XEPersL lifetimes in NaLuF 4:Tb 3+ NPs through adjusting F/Re ratios, which were shown to effectively impact the generation of carrier traps. In addition to the enhanced emission intensity and prolonged decay time in the radioluminescence of NaLuF 4:Tb 3+ NPs with an optimal precursor F/Re ratio of 4.5, a quite low detection limit of 2.01 nGy·s –1 was achieved. Furthermore, the developed fluoride NPs exhibit remarkable luminescence stability. These findings can promote the further exploration of efficient XEPersL nanomaterials with tailored performance in X-PDT and biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Luminescence Properties of Advanced Materials · Lanthanide and Transition Metal Complexes · Atomic and Subatomic Physics Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Optoelectronic Materials and Devices, School of Materials Science and Engineering, Jiangxi University of Science and Technology, Ganzhou 341000, China
Guorui Scientific Innovation Rare Earth Functional Materials (Ganzhou) Co., Ltd., Ganzhou 341000, China
Funding
Double Thousand Plan of Jiangxi Province · National Natural Science Foundation of China · The Innovative Talents Program of Ganzhou · Scientific Research Foundation of Jiangxi University of Science and Technology
References (35)
Show source-provided references
1. 10.1016/j.cej.2022.13557310.1016/j.cej.2022.135573 ↗
2. 10.1038/s41467-022-33489-110.1038/s41467-022-33489-1 ↗
3. 10.3390/ma1603113210.3390/ma16031132 ↗
4. 10.1016/j.cej.2022.13844010.1016/j.cej.2022.138440 ↗
5. 10.1039/D2TC00627H10.1039/D2TC00627H ↗
6. 10.1038/s41377-021-00575-w10.1038/s41377-021-00575-w ↗
7. 10.1002/adom.20210062410.1002/adom.202100624 ↗
8. 10.1038/nmat390810.1038/nmat3908 ↗
9. 10.1038/s41565-021-00922-310.1038/s41565-021-00922-3 ↗
10. 10.1039/D3QI00184A10.1039/D3QI00184A ↗
11. 10.1042/BJ2015094210.1042/BJ20150942 ↗
12. 10.3390/pharmaceutics1303029610.3390/pharmaceutics13030296 ↗
13. 10.1002/adma.20180802410.1002/adma.201808024 ↗
14. 10.1038/s41377-022-00808-610.1038/s41377-022-00808-6 ↗
15. 10.1002/adfm.20200992010.1002/adfm.202009920 ↗
16. 10.1016/j.jlumin.2022.11939310.1016/j.jlumin.2022.119393 ↗
17. 10.1002/adma.20210796210.1002/adma.202107962 ↗
18. 10.1038/s41586-021-03251-610.1038/s41586-021-03251-6 ↗
19. 10.1016/j.jlumin.2023.11992910.1016/j.jlumin.2023.119929 ↗
20. 10.1021/acs.bioconjchem.9b0042910.1021/acs.bioconjchem.9b00429 ↗
21. 10.1021/jacs.5b0171810.1021/jacs.5b01718 ↗
22. 10.1038/nature0877710.1038/nature08777 ↗
23. 10.1016/j.biomaterials.2018.09.00110.1016/j.biomaterials.2018.09.001 ↗
24. 10.1088/0022-3727/38/17/S2910.1088/0022-3727/38/17/S29 ↗
25. 10.1038/lsa.2016.6610.1038/lsa.2016.66 ↗
26. 10.1021/cg700752810.1021/cg7007528 ↗
27. 10.1149/1.306038210.1149/1.3060382 ↗
28. 10.1038/nnano.2014.31710.1038/nnano.2014.317 ↗
29. 10.1002/adom.20140056210.1002/adom.201400562 ↗
30. 10.1039/C7NR02926H10.1039/C7NR02926H ↗
31. 10.1021/nl504123r10.1021/nl504123r ↗
32. 10.1021/acs.jpcc.0c0688410.1021/acs.jpcc.0c06884 ↗
33. 10.1021/acs.jpcc.6b0526110.1021/acs.jpcc.6b05261 ↗
34. 10.1021/jacs.1c1149610.1021/jacs.1c11496 ↗
35. 10.1038/nphoton.2016.4110.1038/nphoton.2016.41 ↗